# 21 CFR § 99.105: Recipients of information

> Federal · Regulations · In force

URL: https://www.frixlaw.com/law-library/statutes/ecfr-21-99.105

## Section

- **Citation:** 21 CFR § 99.105
- **Heading:** Recipients of information
- **Jurisdiction:** Federal
- **Kind:** Regulations
- **Status:** In force
- **Text as of:** September 22, 2026
- **Source:** Publisher's official text
- **Location:** Title 21—Food and Drugs > CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES > SUBCHAPTER A—GENERAL > PART 99—DISSEMINATION OF INFORMATION ON UNAPPROVED/NEW USES FOR MARKETED DRUGS, BIOLOGICS, AND DEVICES > Subpart B—Information To Be Disseminated

## Text

A manufacturer disseminating information on a new use under this part may only disseminate that information to a health care practitioner, a pharmacy benefit manager, a health insurance issuer, a group health plan, or a Federal or State Government agency.

## Nearby sections

- [21 CFR § 99.1 § 99.1 Scope.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.1.md)
- [21 CFR § 99.3 § 99.3 Definitions.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.3.md)
- [21 CFR § 99.101 § 99.101 Information that may be disseminated.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.101.md)
- [21 CFR § 99.103 § 99.103 Mandatory statements and information.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.103.md)
- [21 CFR § 99.105 § 99.105 Recipients of information.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.105.md)
- [21 CFR § 99.201 § 99.201 Manufacturer's submission to the agency.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.201.md)
- [21 CFR § 99.203 § 99.203 Request to extend the time for completing planned studies.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.203.md)
- [21 CFR § 99.205 § 99.205 Application for exemption from the requirement to file a supplemental application.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.205.md)
- [21 CFR § 99.301 § 99.301 Agency action on a submission.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.301.md)
- [21 CFR § 99.303 § 99.303 Extension of time for completing planned studies.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.303.md)
- [21 CFR § 99.305 § 99.305 Exemption from the requirement to file a supplemental application.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.305.md)
- [21 CFR § 99.401 § 99.401 Corrective actions and cessation of dissemination of information.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.401.md)
- [21 CFR § 99.403 § 99.403 Termination of approvals of applications for exemption.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.403.md)
- [21 CFR § 99.405 § 99.405 Applicability of labeling, adulteration, and misbranding authority.](https://www.frixlaw.com/law-library/statutes/ecfr-21-99.405.md)

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/statutes/ecfr-21-99.105. Check the current official text before relying on it. Not legal advice.